Financial News
All News about Sage Therapeutic Com
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/wall-street-4758079_960_720_0.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/price_targets_299.png)
![](https://mms.businesswire.com/media/20211019005298/en/917637/5/Biogen_Logo_Standard_highres.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_1384.jpeg?width=720)
A.I. Breakthrough Could Disrupt the $11 Trillion Medical Sector
October 18, 2021
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/oil-rig-5232047_960_720.jpg)
![](https://mms.businesswire.com/media/20211004005319/en/912444/5/Biogen_Logo_Standard_cmyk_R_highres.jpg)
![](https://mms.businesswire.com/media/20211001005134/en/736779/5/Sage_logo.jpg)
Sage Therapeutics Launches SageCitizen Social Impact Initiative
October 01, 2021
From Sage Therapeutics
Via Business Wire
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_715.jpeg?width=720)
![](https://mms.businesswire.com/media/20210921005386/en/908045/4/C.Benecchi_patrick_mcnamara_photo.jpg)
Sage Therapeutics Appoints Chris Benecchi as Chief Commercial Officer
September 21, 2021
From Sage Therapeutics
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_373.jpg)
![](https://mms.businesswire.com/media/20210915005156/en/736779/5/Sage_logo.jpg)
![](https://mms.businesswire.com/media/20210902005020/en/736779/5/Sage_logo.jpg)
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/valuestock_image_45.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_365.jpg)
![](https://mms.businesswire.com/media/20210804005867/en/736779/5/Sage_logo.jpg)
Via Business Wire
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/price_targets_245.png?width=720)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
Sage Therapeutics Inc (SAGE) Q2 2021 Earnings Call Transcript
August 03, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/depression-image_by_anemone123_from_pixabay_0.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_360.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://mms.businesswire.com/media/20210803005320/en/736779/5/Sage_logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.